MarketPlace

Get an early start on your networking for South Summit 2017 by checking out our marketplace, where you can find profiles on all the Startups, Corporate Partners, Accelerators and Institutions who will be at the event.

I look for a relationships with a

Working on

Who can help my project via

Speratum Cancer Therapeutics
  • Speratum Cancer Therapeutics
TypeStartup Startup interested in Strategic Partnerships, Technological Support, Funding, Management Support, Accelerator Programme, Visibility, Talent
  • Speratum Cancer Therapeutics
  • Biotech
  • |
  • Founded in 2014
  • |
  • 2-5 employees

Pancreatic cancer is the the deadliest cancer. Only 6% of patients survive 5 years. We have discovered and patented a novel, nucleic acid-based therapeutic and efficient nanoparticle-based delivery system. Our technology, co-invented by our company's CEO, was developed at and licensed from Baylor College of Medicine in Houston, Texas, USA. We have discovered a tumor-suppressive molecule which is normally found at high levels in human tissues. In tumors, the level drops significantly, leading to unrestrained cancer growth and aggressiveness. We can synthesize this molecule, and deliver it to tumor cells through the blood. We have demonstrated in peer-reviewed publications that we can reduce tumor size by ~90%, and reduce metastasis by over 70%. In addition, we can sensitize cancer cells to chemotherapy. We have built a state-of-the-art facility where we are conducting R&D studies to test and improve the efficacy and safety of our treatment with the goal of taking it to the clinic.

If you have a proposal on some of these areas, we will gladly analyze:

Christian Roberto Marín-Müller

Christian Roberto Marín-Müller

CEO


Marianne Hütt-Cabezas

Marianne Hütt-Cabezas

Researcher